A Director at Xenon (XENE) is Selling Shares


Yesterday, a Director at Xenon (XENE), Mohammad Azab, sold shares of XENE for $214.

This is Azab’s first Sell trade following 7 Buy transactions. Following Mohammad Azab’s last XENE Sell transaction on December 10, 2018, the stock climbed by 2.3%.

See today’s analyst top recommended stocks >>

The company has a one-year high of $13.85 and a one-year low of $5.41. Currently, Xenon has an average volume of 79.68K.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Xenon Pharmaceuticals, Inc. engages in discovering and developing therapeutics to improve the lives of patients with neurological disorders. It focuses on the treatment of epilepsy. Its products include XEN496, XEN1101, XEN901, and XEN007.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts